Fresenius Medical Care 

€37.24
249
-€0.13-0.35% Thursday 15:15

統計

當日最高
37.9
當日最低
37.09
52週最高
63.68
52週最低
26
成交量
1,854.77
平均成交量
375,351
市值
17.87B
市盈率
-
股息收益率
3.11%
股息
1.16

即將到來

股息

3.11%股息收益率
10年增長
4.45%
5年增長率
0.34%
3年增長率
-3.88%
1年增長率
6.25%

收益

5Nov預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0.31
0.52
0.74
0.95
預期每股收益
0.80663473264
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 0H9X.LSE 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Show more...
首席執行官
Ms. Helen Giza
員工
113639
國家
DE
ISIN
DE0005785802

上市公司